MBM Wealth Consultants LLC Invests $1.07 Million in The Cooper Companies, Inc. (NASDAQ:COO)

MBM Wealth Consultants LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 11,793 shares of the medical device company’s stock, valued at approximately $1,069,000.

Several other institutional investors have also recently bought and sold shares of the business. Ashton Thomas Securities LLC acquired a new stake in shares of Cooper Companies in the third quarter valued at $25,000. Covestor Ltd grew its holdings in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. increased its position in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares in the last quarter. West Financial Advisors LLC bought a new position in shares of Cooper Companies in the fourth quarter worth about $49,000. Finally, Friedenthal Financial acquired a new position in shares of Cooper Companies during the third quarter worth approximately $50,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $95.35 on Wednesday. The firm has a market capitalization of $19.03 billion, a price-to-earnings ratio of 48.90, a price-to-earnings-growth ratio of 2.36 and a beta of 0.99. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average of $96.21 and a 200-day moving average of $99.20.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the company earned $0.87 earnings per share. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Wells Fargo & Company boosted their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Citigroup reduced their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.